However, in the case of HYAL1, we found that mRNA levels significantly decrease in TT in breast cancer respect to NAT, while in colorectal cancer there is a tendency for HYAL1 to decrease in NAT respect to TT although not statistically significant. This evidence concerns the gene BRD2 and breast carcinoma.